AI-generated analysis. Always verify with the original filing.
Vanda Pharmaceuticals Inc. filed an 8-K on February 19, 2026, disclosing matters under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements, including a Form of Performance Restricted Stock Unit Award under the Amended and Restated 2016 Equity Incentive Plan as Exhibit 10.1 under Item 9.01.
Event Type
Disclosure
Mandatory
Variant
8-K
. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February
. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Form of Performance Restricted Stock Unit Award under Amended and Restated 2016 E